Germfree, a Florida-based supplier of controlled aseptic environments, containment and safety solutions, will feature its mobile adaptive bioproduction suite at Interphex, taking place 21-23 March, 2017 at the Javits Center in New York.
The platform is suitable for a wide range of biopharmaceutical production needs, including the production of monoclonal antibodies, therapeutic proteins, viral vector and live virus vaccines.
In addition to designing and producing flexible bioproduction and R&D platforms, Germfree also integrates core equipment including lines of interchangeable laminar flow hoods and containment equipment.
Adaptive trailers offer flexible cleanroom space that is easily configured to required ISO grades as well as biological safety levels up to Biosafety Level (BSL)-3. The units are customised to meet each client’s production and validation requirements, including gas/vapour bio-decontamination.
The company says mobile suites provide a solution for rapid deployment where budget, facility and timeline limitations constrain manufacturing and R&D innovation.
This new approach offers an adaptive platform that can adjust for emerging biopharmaceutical processes as it uses Germfree’s interchangeable casework and laminar flow equipment. Multiple trailers can be joined for future expansion.
“Interphex offers the ideal platform to demonstrate technologies that represent the future of pharmaceutical and biologics development and production,” said Melissa Ashley, Senior Vice President, Interphex. “We are delighted that Germfree will exhibit a mobile adaptive bioproduction suite for attendees to walk through and experience solutions that maximise onsite space and offer personnel safety and containment control in a self-contained platform right on the show floor.”
Germfree will be on booth 3961. Its Mobile Adaptive Bioproduction suite will also be included on the IPS – Integrated Project Services, LLC Technologies Tours occurring at the event on March 22, 2017 from 10:00 am to 1:00 pm. The IPS tours offer insight into technology advancements for innovation and manufacturing technologies and are led by internationally recognised experts.